PĚČ, Ondřej, Petr BOB a Jiří RABOCH. Dissociation in schizophrenia and borderline personality disorder. Online. Neuropsychiatric Disease and Treatment. New Zealand: Dove Medical Press, 2014, roč. 10, March, s. 487-491. ISSN 1176-6328. Dostupné z: https://dx.doi.org/10.2147/NDT.S57627. [citováno 2024-04-24]
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Dissociation in schizophrenia and borderline personality disorder
Autoři PĚČ, Ondřej (203 Česká republika), Petr BOB (203 Česká republika, garant, domácí) a Jiří RABOCH (203 Česká republika)
Vydání Neuropsychiatric Disease and Treatment, New Zealand, Dove Medical Press, 2014, 1176-6328.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30000 3. Medical and Health Sciences
Stát vydavatele Nový Zéland
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 2.154 v roce 2013
Kód RIV RIV/00216224:14740/14:00079327
Organizační jednotka Středoevropský technologický institut
Doi http://dx.doi.org/10.2147/NDT.S57627
UT WoS 000332838500001
Klíčová slova anglicky dissociation; stress-related symptoms; schizophrenia; borderline personality disorder; antipsychotic medication
Štítky kontrola MP, MP, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Martina Prášilová, učo 342282. Změněno: 3. 3. 2015 09:53.
Anotace
Background: Dissociation likely plays a key role in schizophrenia and borderline personality disorder (BPD), although empirical studies that compare specific manifestations of these symptoms in schizophrenia and BPD are rare. In this context, the purpose of this study was to compare the occurrence of dissociative and other psychopathological symptoms in these disorders, and to assess the possible influence of antipsychotic medication on the dissociative symptoms. Methods: We assessed 31 patients with schizophrenia and 36 patients with BPD. Dissociative symptoms were measured by the Dissociative Experiences Scale (DES), symptoms related to stress and traumatic experiences were assessed using the Trauma Symptom Checklist-40 (TSC-40), and other psychopathological symptoms were measured with the Health of the Nation Outcome Scales (HoNOS). We also assessed actual daily doses of antipsychotic medication in chlorpromazine equivalents in all participants. Results: The results show that symptoms of traumatic stress measured by the TSC-40 had significantly higher scores in the BPD group. The data also show that dissociative symptoms (DES) were significantly correlated with symptoms of traumatic stress (TSC-40) and with symptoms assessed by the HoNOS. Remarkably significant correlations were found between levels of antipsychotic medication and the DES and between antipsychotic medication and the depersonalization/derealization component of the DES in BPD patients. Conclusion: The results support an important role of dissociative processes in schizophrenia and BPD and suggest a significant relationship between manifestations of dissociative symptoms in BPD and antipsychotic medication.
Návaznosti
ED1.1.00/02.0068, projekt VaVNázev: CEITEC - central european institute of technology
VytisknoutZobrazeno: 24. 4. 2024 08:11